Tyrosine kinase inhibitors as cancer therapy.
Nichols
Gwen L
GL
Department of Medicine, Divisions of Hematology and Oncology, Columbia University College of Physicians and Surgeons, New York, New York, USA. nichols@cuccfa.ccc.columbia.edu
D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000473:pathology; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors* / Q000494:pharmacology*; D015398:Signal Transduction
D004791:Enzyme Inhibitors; D011505:Protein-Tyrosine Kinases